Moderna said it secured a European Commission contract to supply its respiratory syncytial virus (RSV) vaccine to six European countries. The announcement is incrementally positive for revenue visibility, but the contract size/financial impact was not disclosed.
Moderna said it secured a European Commission contract to supply its respiratory syncytial virus (RSV) vaccine to six European countries. The announcement is incrementally positive for revenue visibility, but the contract size/financial impact was not disclosed.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
